Literature DB >> 7821118

Effects of exercise-induced sympathoadrenergic activation on portal blood flow.

T Iwao1, A Toyonaga, M Ikegami, M Sumino, K Oho, M Sakaki, H Shigemori, K Tanikawa, J Iwao.   

Abstract

We examined the relationship between portal venous blood flow and sympathoadrenergic activation after muscle exercise. For this purpose, we used echo Doppler and measured plasma noradrenaline concentration before and after mild (7 metabolic units, N = 8) and maximal exercise (14 metabolic units, N = 8) in 16 patients without significant disease. Portal venous flow did not change after mild exercise. In contrast, a significant reduction in portal venous flow was observed after maximal exercise (P < 0.01). This was due to reductions in both cross-sectional area of the portal vein (P < 0.01) and portal venous velocity (P < 0.01). Overall, there were significant inverse relationships between the change in plasma noradrenaline concentration and that in cross-sectional area of the portal vein [r = -0.44, P < 0.01 (absolute change); r = -0.47, P < 0.01 (relative change)], that in portal venous velocity (r = -0.63, P < 0.01; r = -0.61, P < 0.01), and that in portal venous flow (r = -0.54, P < 0.01; r = -0.59, P < 0.01). These results suggest that the reduction in portal venous flow after exercise is related to the degree of sympathoadrenergic activation. This reduction may be due mainly to splanchnic vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7821118     DOI: 10.1007/bf02063940

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  11 in total

1.  Pulsed Doppler with B-mode imaging for quantitative blood flow measurement.

Authors:  R W Gill
Journal:  Ultrasound Med Biol       Date:  1979       Impact factor: 2.998

2.  Duplex ultrasound measurement of postprandial intestinal blood flow: effect of meal composition.

Authors:  G L Moneta; D C Taylor; W S Helton; M W Mulholland; D E Strandness
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

3.  Portal hemodynamics after meal in normal subjects and in patients with chronic liver disease studied by echo-Doppler flowmeter.

Authors:  D Pugliese; K Ohnishi; T Tsunoda; C Sabba; O Albano
Journal:  Am J Gastroenterol       Date:  1987-10       Impact factor: 10.864

4.  Portal venous hemodynamics in chronic liver disease: effects of posture change and exercise.

Authors:  K Ohnishi; M Saito; T Nakayama; S Iida; F Nomura; H Koen; K Okuda
Journal:  Radiology       Date:  1985-06       Impact factor: 11.105

5.  Maximal oxygen uptake.

Authors:  J H Mitchell; G Blomqvist
Journal:  N Engl J Med       Date:  1971-05-06       Impact factor: 91.245

6.  Reduced portosystemic hemodynamic responsiveness after orthostasis in patients with cirrhosis.

Authors:  T Iwao; A Toyonaga; M Ikegami; M Sumino; K Oho; M Sakaki; H Shigemori; K Tanikawa; J Iwao
Journal:  Dig Dis Sci       Date:  1993-07       Impact factor: 3.199

7.  Automated analysis for plasma epinephrine and norepinephrine by liquid chromatography, including a sample cleanup procedure.

Authors:  A Yamatodani; H Wada
Journal:  Clin Chem       Date:  1981-12       Impact factor: 8.327

8.  Evaluation of postprandial hyperemia in superior mesenteric artery and portal vein in healthy and cirrhotic humans: an operator-blind echo-Doppler study.

Authors:  C Sabbá; G Ferraioli; P Genecin; L Colombato; P Buonamico; E Lerner; K J Taylor; R J Groszmann
Journal:  Hepatology       Date:  1991-04       Impact factor: 17.425

9.  Noninvasive measurement of portal venous blood flow in patients with cirrhosis: effects of physiological and pharmacological stimuli.

Authors:  D Alvarez; R Mastai; A Lennie; G Soifer; D Levi; R Terg
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

10.  Effect of meal on portal hemodynamics in healthy humans and in patients with chronic liver disease.

Authors:  S Gaiani; L Bolondi; S Li Bassi; V Santi; G Zironi; L Barbara
Journal:  Hepatology       Date:  1989-06       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.